Abstract This work presents a novel electrochemical method for the determination of oxcarbazepine (OXC) in urine and pharmaceutical samples using a flow injection analysis (FIA) system coupled to multiple-pulse amperometric… Click to show full abstract
Abstract This work presents a novel electrochemical method for the determination of oxcarbazepine (OXC) in urine and pharmaceutical samples using a flow injection analysis (FIA) system coupled to multiple-pulse amperometric (MPA) detection on a boron-doped diamond electrode (BDDE). The unique voltammetric profile of OXC on the BDDE, consisting of two electrochemical oxidation processes between +1.6 and +1.8 V versus Ag/AgCl/3.0 mol L−1 KCl generating cationic radical species that undergo two electrochemical reduction processes at −0.2 and −1.0 V, was used for the application of MPA detection for the selective detection of OXC in biological samples. Briefly, OXC determination consisted in the application of a three-potential waveform: (1) at +1.7 V/200 ms, generator potential pulse for oxidation of OXC; (2) at −1.1 V/30 ms, collector potential pulse for reduction of the generated product and OXC quantification; (3) at −1.3 V/300 ms, potential pulse for cleaning the BDDE. This strategy enabled OXC determination in urine free from the interference of ascorbic and uric acids. The method showed high repeatability (RSD
               
Click one of the above tabs to view related content.